BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19539938)

  • 1. On-line racemization by high-performance liquid chromatography.
    Cannazza G; Carrozzo MM; Battisti U; Braghiroli D; Parenti C
    J Chromatogr A; 2009 Jul; 1216(30):5655-9. PubMed ID: 19539938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomerization of chiral 2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4] benzothiadiazine 5,5-dioxide by stopped-flow multidimensional HPLC.
    Cannazza G; Carrozzo MM; Braghiroli D; Parenti C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(1):192-9. PubMed ID: 18515197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantiomerization and hydrolysis of (+/-)-7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide by stopped-flow multidimensional high-performance liquid chromatography.
    Cannazza G; Carrozzo MM; Braghiroli D; Parenti C
    J Chromatogr A; 2008 Nov; 1212(1-2):41-7. PubMed ID: 18951549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of enantiomerization of chiral 3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide type compounds.
    Cannazza G; Braghiroli D; Tait A; Baraldi M; Parenti C; Lindner W
    Chirality; 2001 Feb; 13(2):94-101. PubMed ID: 11170252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, stereoselective synthesis, configurational stability and biological activity of 7-chloro-9-(furan-3-yl)-2,3,3a,4-tetrahydro-1H-benzo[e]pyrrolo[2,1-c][1,2,4]thiadiazine 5,5-dioxide.
    Carrozzo MM; Battisti UM; Cannazza G; Puia G; Ravazzini F; Falchicchio A; Perrone S; Citti C; Jozwiak K; Braghiroli D; Parenti C; Troisi L
    Bioorg Med Chem; 2014 Sep; 22(17):4667-76. PubMed ID: 25126714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of enantiomerization and hydrolysis kinetic parameters of chiral N-alkylbenzothiadiazine derivatives.
    Carrozzo MM; Cannazza G; Battisti U; Braghiroli D; Parenti C
    Chirality; 2010 May; 22(4):389-97. PubMed ID: 19575466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of stereo and chemical stability of chiral compounds.
    Cannazza G; Battisti U; Carrozzo MM; Brasili L; Braghiroli D; Parenti C
    Chirality; 2011 Nov; 23(10):851-9. PubMed ID: 21932212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral resolution of the enantiomers of 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide using high-performance liquid chromatography on cellulose-based chiral stationary phases.
    Cannazza G; Braghiroli D; Baraldi M; Parenti C
    J Pharm Biomed Anal; 2000 Aug; 23(1):117-25. PubMed ID: 10898161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantiomeric resolution with a new chiral stationary phase of 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide, a cognition-enhancing benzothiadiazine derivative.
    Uzunov DP; Zivkovich I; Pirkle WH; Costa E; Guidotti A
    J Pharm Sci; 1995 Aug; 84(8):937-42. PubMed ID: 7500277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusually high enantioselectivity in high-performance liquid chromatography using cellulose tris(4-methylbenzoate) as a chiral stationary phase.
    Cirilli R; Alcaro S; Fioravanti R; Secci D; Fiore S; La Torre F; Ortuso F
    J Chromatogr A; 2009 May; 1216(22):4673-8. PubMed ID: 19394945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of racemisation of the enantiomers of glitazone drug compounds at different pH using chiral HPLC and chiral CE.
    Jamali B; Bjørnsdottir I; Nordfang O; Hansen SH
    J Pharm Biomed Anal; 2008 Jan; 46(1):82-7. PubMed ID: 17942259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of a racemic mixture of 8-chloro-2-(2,6-difluorophenylmethyl)-2,3-dihydro-3-methyl-1,2,5-benzothiadiazepin-4(5h)-one 1,1-dioxide into a single enantiomer via a chromatographic resolution/racemization method.
    La Torre F; Cirilli R; Ferretti R; Gallinella B; Costi R; Di Santo R
    Chirality; 2003 May; 15(5):429-32. PubMed ID: 12692888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of thin-layer chromatography in enantiomeric chiral analysis-an overview.
    Aboul-Enein HY; El-Awady MI; Heard CM; Nicholls PJ
    Biomed Chromatogr; 1999 Dec; 13(8):531-7. PubMed ID: 10611607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute structure determination as a reference for the enantiomeric resolution of racemic mixtures of cyclophosphazenes via chiral high-performance liquid chromatography.
    Coles S; Davies D; Hursthouse M; Yeşilot S; Coşut B; Kiliç A
    Acta Crystallogr B; 2009 Jun; 65(Pt 3):355-62. PubMed ID: 19461146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of high-performance liquid chromatography of cyclotriphosphazene derivatives with one or two equivalent stereogenic centres.
    Beşli S; Davies DB; Kiliç A; Shaw RA; Sahin S; Uslu A; Yeşilot S
    J Chromatogr A; 2006 Nov; 1132(1-2):201-5. PubMed ID: 16965786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of preparative batch HPLC, supercritical fluid chromatography, steady-state recycling, and simulated moving bed for the resolution of a racemic pharmaceutical intermediate.
    Yan TQ; Orihuela C; Swanson D
    Chirality; 2008 Feb; 20(2):139-46. PubMed ID: 18092299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No carrier added synthesis of O-(2'-[18F]fluoroethyl)-L-tyrosine via a novel type of chiral enantiomerically pure precursor, NiII complex of a (S)-tyrosine Schiff base.
    Krasikova RN; Kuznetsova OF; Fedorova OS; Maleev VI; Saveleva TF; Belokon YN
    Bioorg Med Chem; 2008 May; 16(9):4994-5003. PubMed ID: 18378460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient method development strategy for challenging separation of pharmaceutical molecules using advanced chromatographic technologies.
    Xiao KP; Xiong Y; Liu FZ; Rustum AM
    J Chromatogr A; 2007 Sep; 1163(1-2):145-56. PubMed ID: 17628579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of enantiomeric excess of ethyl 3,5-dihydroxy-6-benzyloxy hexanoate by chiral reverse phase high performance liquid chromatography.
    Liu JH; Yu BY; Chen YJ
    Chirality; 2008 Jan; 20(1):51-3. PubMed ID: 17990330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral derivatization reagents for drug enantioseparation by high-performance liquid chromatography based upon pre-column derivatization and formation of diastereomers: enantioselectivity and related structure.
    Sun XX; Sun LZ; Aboul-Enein HY
    Biomed Chromatogr; 2001 Apr; 15(2):116-32. PubMed ID: 11268052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.